PubMed · 2026

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial

Pratley RE, Denham DS, Trivedi R, et al. (2026). Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial. Nat Med.

Nat Med

Source: https://pubmed.ncbi.nlm.nih.gov/42260100/

Last reviewed September 19, 2026. By the PeptIQ team.

View original source

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.